摘要
目的:探讨三氧化二砷(arsen ic trioxide,ATO)对白血病耐药细胞株K562/A02细胞表达的基质金属蛋白酶2,9(MMP-2、9)活性的影响。方法:用MTT法检测不同浓度ATO对K562/A02细胞的增殖抑制率;用明胶酶谱法检测ATO对K562/A02细胞MMP-2、9活性的影响。结果:K562/A02细胞的MMP-2、9活性条带在对照组以MMP-2(72KD)最宽,MMP-9次之,MMP-2(62KD)最窄。MMP-2、9经0.05μMATO处理后在24、48小时与对照组比较无明显差异(P>0.05),72小时差异才具有显著性(P<0.05)。MMP-2、9的活性经0.4μM和3.2μM的ATO处理后随作用时间延长而抑制作用也逐渐增强,与对照组比较差异均有显著性(P<0.05)。结论:ATO可以有效抑制K562/A02细胞的MMP-2、9的活性,但其作用的强度与剂量及作用时间有关。ATO对MMP-2、9的活性的抑制可能是其抗白血病细胞血管新生的机制之一。
Objective :To investigate the effect of the expression of the activity of MMP- 2, 9 in multidrug resistant leukemic cell K.562/A02 treated by arsenic trioxide (ATO). Methods: The growth inhibitory activity of different concentrations of ATO in K562/A02 cell was detected by MTT assay. The activity of MMP- 2, 9 expressed by K562/A02 cells was assessed by gelatin zymography assay. Results: K562/A02 cells expressed both MMP -2 and MMP-9. Among MMP-2(72KD), MMP-2(62KD) and MMP-9 in the control group, the electrophoresis strip of MMP-2 (72KD) was the widest. After seeded 72h, the activity of MMP-2 was inhibited by 0.05μM ATO (P〈0.05). With the increase Of ATO incubation time, the inhibited effect was reinforced by 0.4 and 3.2μM ATO. Conclusion: ATO can inhibit the expression of the activity of MMP-2, 9, but it is influenced by the dose and time. One of the possible mechanisms of anti-leukemic angiogenesis by ATO may be achieved by inhibiting the expression of MMP-2, 9.
出处
《现代肿瘤医学》
CAS
2006年第8期923-925,共3页
Journal of Modern Oncology